These industries are also witnessing marked increases in R & D activities, which have far-reaching effects on the drug discovery information market. Now that competition in drug discovery is hotter than ever, firms are increasingly seeking out analyses based on information technologies to help them through the process from target screening all the way up until lead optimization.
Science and technology developments greatly affect the drug discovery informatics market. Many innovations, such as artificial intelligence (AI), machine learning and data analytics are gradually being integrated into informatics platforms. These technologies boost data processing power, so researchers can draw useful inferences and speed up the development of new drugs.
Massive amounts of data are generated in the process of drug discovery-the management and analysis thereof are a major factor contributing to that market's functioning. Drug discovery informatics platforms that provide powerful offerings for dealing with large quantities of data, handling information integration and analysis help to make more intelligent decision making. The eventual result is a markedly shorter drug discovery pipeline.
In view of the stringent regulatory requirements imposed by health authorities, the drug discovery informatics market is under great pressure. Informatics solution providers must strictly comply with regulatory standards related to data integrity, security, and privacy. Those companies that can provide solutions which match or surpass these standards are able to gain an advantage in the marketplace.
A major market factor is the adaption of cloud computing for drug discovery informatics.
Because informatics solutions are cloud-based, they offer scalability and flexibility so that researchers can access and analyse data from any location. As the trend of cloud-building spreads, it is helping improve collaboration and data-sharing capabilities within the drug discovery system. Drug discovery informatics market is affected by the trend toward personalized medicine.
Informatics platforms capable of analysing patient data, genetic information and biomarkers are needed to identify possible targets for personalized therapies. As the trend toward precision medicine becomes more pronounced, people are increasingly looking for informatics solutions that suit different forms of individualized treatment.
A wider range of emerging markets is getting involved in drug discovery and a globalization of research efforts influence the market for informatics.
Report Attribute/Metric | Details |
---|---|
Market Size Value In 2022 | USD 3.1 Billion |
Market Size Value In 2023 | USD 3.43 Billion |
Growth Rate | 10.8% (2023-2032)Base Year2022Market Forecast Period2023-2032Historical Data2018- 2022Market Forecast UnitsValue (USD Billion)Report CoverageRevenue Forecast, Market Competitive Landscape, Growth Factors, and TrendsSegments CoveredProduct, Mode, Service, and RegionGeographies CoveredNorth America, Europe, Asia Pacific, and the Rest of the WorldCountries CoveredThe US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and BrazilKey Companies Profiled Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault SystèmesKey Market OpportunitiesProduct releases and R&D by significant critical playersKey Market DynamicsGrowing emphasis on medication discoveryThere is a growing need to control medication discovery and development expenses.Increase in R&D spendingThe chronic illness burden is growing. |
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)